March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Intravitreal Ranibizumab For Choroidal Neovascularisation In Fundus Flavimaculatus
Author Affiliations & Notes
  • Sorinela Roata
    Ophtalmology Department, Central Regional Hospital Orleans, Orleans, France
  • Belynda Tita
    Ophtalmology Department, Central Regional Hospital Orleans, Orleans, France
  • Mounir Drief
    Ophtalmology Department, Central Regional Hospital Orleans, Orleans, France
  • Pierre Bonicel
    Ophtalmology Department, Central Regional Hospital Orleans, Orleans, France
  • Footnotes
    Commercial Relationships  Sorinela Roata, None; Belynda Tita, None; Mounir Drief, None; Pierre Bonicel, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 943. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sorinela Roata, Belynda Tita, Mounir Drief, Pierre Bonicel; Intravitreal Ranibizumab For Choroidal Neovascularisation In Fundus Flavimaculatus. Invest. Ophthalmol. Vis. Sci. 2012;53(14):943.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We present a case-based study of late-onset fundus flavimaculatus complicated with choroidal neovascularisation.A treatment with intravitreal ranibizumab was performed.

Methods: : Our patient, a 65 years old woman, has been previously diagnosed with late onset Stargardt disease upon complete ophtalmologic examination, including IVFA,EOG and multifocal ERG.We documented juxtafoveolar choroidal neovascularisation using IVFA and OCT.A treatment with intravitreal ranibizumab was performed.

Results: : We noted the resorbtion of the subretinal fluid and an increase in visual acuity with disparition of metamorphopsias.

Conclusions: : Late age of onset has been reported in 20% of Stargardt cases.The lipoproteic scrap deposits could induce alterations of the pigmentary epithelium and Bruch membrane rupture followed by choroidal neovascularisation.This entity has a slower progression and a better visual prognosis. Treatment by intravitreal ranibizumab induced total regression of the choroidal neovascularisation.

Keywords: choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×